Yuancheng Ryan Lu, a geneticist at the Whitehead Institute, has been working on a groundbreaking method to rejuvenate aging retinal nerve cells, potentially restoring eyesight in older adults with glaucoma. After years of unsuccessful attempts, Lu introduced three genes into mouse eyes, aiming to revert cells to a younger state. His recent experiment showed promising signs of new growth, leading to a clinical trial set to begin this year. This trial is part of a larger effort to explore ‘partial reprogramming’ of cells, a field that has garnered significant interest and investment. The goal is to rejuvenate old organs and possibly the entire human body, though risks such as loss of cell function and cancer remain. This research builds on the discovery by Shinya Yamanaka that adult cells can be reprogrammed to an embryonic-like state, a finding that revolutionized stem cell research.
QUESTION: How might the ability to rejuvenate cells impact the way we understand and approach aging in the future?
This method to reverse cellular aging is about to be tested in humans
